On Jul. 29, 2020, PharmaCyte Biotech announced that the COVID-19 Molecular tests it has licensed from Hai Kang Life Corp. have received the CE mark. The CE mark was given to the RT-PCR and ERT-PCR tests.

The Declaration of Conformity for the COVID-19 tests confirms that the tests meet the Essential Requirements of the European Communityﾒs In-Vitro Diagnostic Medical Device Directive (IVDD 98/79/EC), permitting export and sales of the product as an IVD in the European Union member countries.